For US Healthcare Professionals, Patients, and Caregivers

For US Patients and Caregivers

For US Healthcare Professionals

ORZEYFUL™ (oveporexton) tablets logo

COMING SOON

ORZEYFULTM is an investigational drug under review by the FDA.

It is not approved nor available at this time.

Stay connected

Stay informed about ORZEYFUL (oveporexton).

Select one*

*Required.

By clicking “Sign up,” you confirm you are at least 18 years old, are a U.S. resident, and consent to Takeda, its affiliates, and vendors/service providers acting on Takeda’s behalf using the information you provide, to send you marketing and promotional emails and collect and use information about your engagement with our emails and other digital content (such as opens, clicks, and website interactions). These emails may include product and disease state information, information about clinical trials, invitations to market research, and information about events or programs for patients, caregivers, or the public. You consent to Takeda, its affiliates, and vendors/service providers acting on Takeda’s behalf, de-identifying and aggregating your information for internal business purposes. Takeda will not make any efforts to re-identify data once de-identified.

You acknowledge that this consent will remain in effect until you revoke it. You may opt out of receiving communications at any time by clicking the “unsubscribe” link included in any communication. For more information about our collection and use of personal information and your privacy rights, please refer to our Privacy Notice.

Your privacy is important to us. For more information regarding collection and use of personal data, please refer to our Privacy Notice.

Thank you